For example: Apple Inc, UTIL, Aluminum
OBALON THERAPEUTICS INC
NASDAQ:OBLN
Market Close 03/05
2.78 USD +0.13 (+4.91%)
OPEN:
2.68
DAY RANGE:
2.30 - 2.98
PE:
-0.53
PB:
3.68
PS:
2.62
WTD % -18.95
MTD % -18.95
QTD % 85.33
YTD % 85.33
* Updated at market close
OBALON THERAPEUTICS INC (NASDAQ:OBLN) opened on Mar 5, 2021 at 2.68 USD and edged higher by 4.91%. The intraday price range was 2.30 - 2.98 USD and eventually ended the session at 2.78 USD. The stock trade volume was 2.70 M shares. The company's 52-week range is 0.62 - 10.77 USD.
Trading Statistics (Market Close Mar 5, 2021)
Market Cap 21.49 M
Outstanding Stock 2.33 M
Dividend 0.00
Dividend Yield 0.00
EPS -13.20
YTD Change 85.33%
52 Week's Range 0.62 - 10.77
Key Ratio & Margins (Market Close Mar 5, 2021)
Price/Earning -0.53
Price/Book Value 3.68
Price/Sales 2.62
ROA -
ROE -
Debt/Equity 1.29
Company Self Description
OBALON THERAPEUTICS INC, a vertically integrated medical device company focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The company offers the Obalon balloon system designed to provide weight loss in obese patients. It was founded in 2008 and is headquartered in Carlsbad, California, United States.
Business Information
OBALON THERAPEUTICS INC
Sector Health Care
Industry Health Care Equipment & Supplies
Exchange NASDAQ
Top Competitors (Market Close Mar 5, 2021)
  OBLN AEMD ATOS NVIV
Daily Change (%) 4.91 -1.04 4.21 19.78
WTD (%) -18.95 -13.18 -18.01 -5.22
MTD (%) -18.95 -13.18 -18.01 -5.22
QTD (%) 85.33 -22.67 134.74 34.57
YTD (%) 85.33 -22.67 134.74 34.57
52-Week Change (%) 113.85 -14.35 81.32 -77.75
Stock Performance (Market Close Mar 5, 2021)
  OBLN AEMD ATOS NVIV
Daily Change (%) 4.91 -1.04 4.21 19.78
WTD (%) -18.95 -13.18 -18.01 -5.22
MTD (%) -18.95 -13.18 -18.01 -5.22
QTD (%) 85.33 -22.67 134.74 34.57
YTD (%) 85.33 -22.67 134.74 34.57
52-Week Change (%) 113.85 -14.35 81.32 -77.75
Key Fundamentals (Market Close Mar 5, 2021)
  OBLN AEMD ATOS NVIV
Market Cap 21.49 M 23.09 M 23.18 M 23.08 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -425.30% -6,468.10% 0.00 0.00
P/E Ratio -0.53 -0.94 -1.38 9.25
Price to Sales Ratio 2.62 63.24 0 0
Price to Book Ratio 3.68 7.43 0.65 0.87
Enterprise Value to EBITDA -1.00 -2.37 0.64 0.24
ROA - -164.70% -102.20% -65.20%
ROE - -259.00% -118.60% -78.30%
Debt/Equity 1.29 0.75 0.33 0.14
Asset Turnover Ratio 0.24 0.03 0 0
Current Ratio 1.66 2.21 3.96 7.77
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 9.10 M 9.91 M 3.39 M 4.04 M
Cost Of Revenue 5.42 M 4.83 M 2.81 M 2.50 M
Gross Profit 3.68 M 5.09 M 584,000.00 1.54 M
Selling General & Administrative Expenses 29.95 M 28.83 M 10.22 M 3.49 M
Research & Development 10.70 M 10.65 M 9.87 M 12.98 M
Operating Income -37.15 M -34.63 M -19.52 M -14.97 M
Net Income -37.38 M -34.77 M -20.47 M -15.55 M
EPS -19.60 -20.80 -48.50 -271.40
Diluted EPS -19.60 -20.80 -48.50 -271.40
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 386,000.00 1.78 M 2.04 M 2.99 M
Cost Of Revenue 679,000.00 1.23 M 1.50 M 1.42 M
Gross Profit -293,000.00 543,000.00 532,000.00 1.57 M
Selling General & Administrative Expenses 4.33 M 6.20 M 6.85 M 5.84 M
Research & Development 1.79 M 2.44 M 2.34 M 2.37 M
Operating Income -6.41 M -8.10 M -8.69 M -6.68 M
Net Income -6.77 M -8.29 M -8.75 M -6.75 M
EPS -2.50 -3.60 -3.60 -3.50
Diluted EPS -2.50 -3.60 -3.60 -3.50
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 28.65 M 51.76 M 78.06 M 13.80 M
Cash & Cash Equivalents 21.19 M 21.11 M 72.98 M 3.36 M
Total Assets 30.39 M 53.10 M 78.78 M 14.22 M
Total Current Liabilities 17.23 M 10.01 M 4.59 M 5.57 M
Total Liabilities 17.28 M 17.99 M 14.47 M 14.66 M
Shareholder's Equity 13.11 M 35.11 M 64.31 M -55.14 M
Outstanding Stock 2.33 M 1.74 M 1.68 M 0.00
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 17.02 M 29.91 M 28.65 M 35.31 M
Cash & Cash Equivalents 13.51 M 24.68 M 21.19 M 21.55 M
Total Assets 19.20 M 32.37 M 30.39 M 36.88 M
Total Current Liabilities 10.09 M 25.03 M 17.23 M 7.28 M
Total Liabilities 10.81 M 25.85 M 17.28 M 16.73 M
Shareholder's Equity 8.39 M 6.52 M 13.11 M 20.15 M
Outstanding Stock 2.40 M 2.35 M 2.33 M 1.78 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -29.43 M -30.62 M -19.37 M -11.39 M
Capital Expenditures -1.28 M -1.04 M -352,000.00 -133,000.00
Net Cash Flow from Investing Activities 19.52 M -21.86 M 6.20 M 2.78 M
Net Cash Flow from Financial Activities 9.99 M 613,000.00 82.79 M 5.06 M
Free Cash Flow -30.71 M -31.67 M -19.72 M -11.53 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -4.36 M -30.62 M -19.37 M -11.39 M
Capital Expenditures -1,000.00 -19,000.00 -415,000.00 -210,000.00
Net Cash Flow from Investing Activities -1,000.00 2.53 M 5.19 M -7.32 M
Net Cash Flow from Financial Activities -6.81 M 10.61 M -135,000.00 9.95 M
Free Cash Flow -4.36 M -9.66 M -5.83 M -5.50 M
Key Ratios (Market Close Mar 5, 2021)
Valuation Ratios 2021 2020 2019 2018
P/E Ratio -0.53 -0.88 -1.06 -1.21
Price to Sales Ratio 2.62 3.49 4.33 4.88
Price to Book Ratio 3.68 3.28 2.31 0.00
Enterprise Value to EBIT -1.00 -3.00 -8.00 0.00
Enterprise Value to EBITDA -1.00 -3.30 -7.88 0.00
Profitability Ratios 2021 2020 2019 2018
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - - -106.60%
ROE - - - -202.80%
Liquidity Ratios 2021 2020 2019 2018
Working Capital 11.42 M 41.74 M 73.47 M 8.24 M
Current Ratio 1.66 5.17 17.00 2.48
Efficiency & Capital Structure Ratios 2021 2020 2019 2018
Debt Equity Ratio 1.29 0.51 0.23 -0.27
Asset Turnover Ratio - - - 0.26
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.